Articles tagged "Multiple system atrophy(MSA): Clinical features"

MDS Virtual Congress 2021
Plasma Short-Chain Fatty Acids Differences in Multiple System Atrophy from Parkinson’s Disease
XQ. He, YW. Qian, SQ. Xu, Y. Zhang, CJ. Mo, XD. Yang, Q. Xiao (Shanghai, China)
Objective: We aimed to investigate the plasma short-chain fatty acids (SCFAs) in multiple system atrophy (MSA) patients and to identify the potential differential diagnostic ability.…
MDS Virtual Congress 2021
The Implications of Pyramidal Signs in Multiple System Atrophy
C. Lin, A. Viswanathan, T. Chen, P. Faust, S. Kuo (New York, USA)
Objective: To determine pyramidal signs in multiple system atrophy (MSA) and the associations with other clinical characteristics. Background: The clinical manifestations of MSA are comprised…
MDS Virtual Congress 2020
Sleep-related Symptoms in Multiple System Atrophy: Determinants and Impact on disease severity
J.Y Lin, L.Y Zhang, B. Cao, QQ. Wei, H.F Shang (Chengdu, China)
Objective: To investigate the prevalence and determinants of sleep-related symptoms in multiple system atrophy (MSA) and the impact of sleep disturbances on disease severity. Background:…
MDS Virtual Congress 2020
Towards a scoring system to distinguish early parkinsonian variant of multiple system atrophy from Parkinson’s disease
P. Millar Vernetti, J.A Palma, L. Norcliffe-Kaufmann, M. Pérez, A. Fanciulli, F. Krismer, W. Singer, P. Low, M.T Pellecchia, H.J Kim, C. Shibao, A. Peltier, I. Biaggioni, M.J Martí, C. Terroba-Chambi, M. Merello, D. Goldstein, R. Freeman, C. Gibbons, S. Vernino, G. Wenning, H. Kaufmann (New York, NY, USA)
Objective: To develop a clinical score to distinguish between the parkinsonian variant of multiple system atrophy (MSA-P) and Parkinson’s disease (PD). Background: The differential diagnosis…
MDS Virtual Congress 2020
Disease stage and UMSARS progression: Implications for clinical trials
M. Pérez, J.A Palma, L. Norcliffe-Kaufmann, P. Millar Vernetti, W. Singer, P. Low, M.T Pellecchia, H.J Kim, C. Shibao, A. Peltier, I. Biaggioni, D. Giraldo, M.J Martí, A. Fanciulli, C. Terroba-Chambi, M. Merello, D. Goldstein, R. Freeman, C. Gibbons, S. Vernino, F. Krismer, G. Wenning, H. Kaufmann (New York, NY, USA)
Objective: To study the rate of progression of multiple system atrophy (MSA) and assess for a potential ceiling effect of the Unified Multiple System Atrophy…
MDS Virtual Congress 2020
Relationship between REM sleep without atonia and sleep architecture in multiple system atrophy
Y. Saitoh, M. Miyazaki, A. Tsuru, Y. Takahashi (Kodaira, Tokyo, Japan)
Objective: To investigate whether REM sleep without atonia (RWA) is associated with sleep architecture in patients with multiple system atrophy (MSA). Background: In MSA patients,…
MDS Virtual Congress 2020
Treatment of Neurogenic Orthostatic Hypotension (nOH) in Multiple System Atrophy (MSA) with a wearable Pneumatic Compression Garment utilising Soft Robotics
N. Sawal, H. Singh, A. Beri (Chandigarh, India)
Objective: To use a novel Pneumatic Garment device for treatment of nOH in MSA. Background: nOH is present in 66-90% of patients with MSA and…
MDS Virtual Congress 2020
Atypical Psychogenic Nonepileptic Seizure (PNES) preceding Multiple System Atrophy (MSA)
A. Shahinian, T. Mehta, A. Betcher, P. Janda, J. Mahajan, A. Vickers (Las Vegas, NV, USA)
Objective: To share a case report of Atypical PNES and MSA. Background: Multiple system atrophy (MSA) is a rare neurodegenerative diagnosis that clinically presents with…
MDS Virtual Congress 2020
Clinical profile and cerebral metabolic characteristic of cognitive impairments in multiple system atrophy
C. Shen, F.T Liu, JJ. Ge, P. Wu, C.T Zuo, J. Wang (Shanghai, China)
Objective: This study aimed to characterize the cognitive profiles of multiple system atrophy (MSA) and explore the possible mechanisms involved using 18F-fluorodeoxyglucose (FDG) Positron Emission…
MDS Virtual Congress 2020
Characterising Oromandibular Dystonia in Multiple System Atrophy: A video analysis
Y. Thongchuam, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)
Objective: To characterise craniofacial manifestations in patients with MSA and explore the relationship between OMD and other related symptoms and treatment. Background: According to the…